Wegovy launch

Quote

anonymous

Guest
Several questions about this impending launch:
What is the hurry to launch?
Why will we be selling a drug from June 10th-June 16th that cannot be sampled or written?
Why would we not wait to launch until after the summer shutdown? Realize, that as nice as a summer shutdown is with no company emails and no company responsibility, the Obesity reps will be fielding calls from confused offices everyday all day.
Why put Wegovy in a single use, single dose pen when you know there are tolerability issues and you know, despite being off-label, thousands of people use "in-between" doses of Saxenda so that they can stay on therapy and lose weight?
Why would we not let the reps at least have some input on the initial targets for this launch? News Flash Novo: Super busy IM and FP doctors that write a lot of GLP-1 for diabetes, in most cases, are not the big Obesity AOM writers!
Most importantly, why did we eliminate every level of management above the DM level that had any familiarity with the uniqueness of the obesity market?
 




Let’s rush so we can look busy. Then when it becomes a failure we will have to have another re-org.
Then we will be rolled into pods selling sema in January.

hurry+ busy work=disaster = lay off
 


An earlier launch will give our DMs more time to be the “first” with a new spreadsheet or tracker that will revolutionize selling!!!! Stay tuned! It will be amazing and something nobody has ever done before!!!
 


anonymous said:
An earlier launch will give our DMs more time to be the “first” with a new spreadsheet or tracker that will revolutionize selling!!!! Stay tuned! It will be amazing and something nobody has ever done before!!!
Click to expand...
…especially if they are former H-managers with no knowledge of the market! This is going to be a great launch!
 








anonymous said:
Everyone on Saxenda put on wegovy
Everyone on ozempic for weight loss put on wegovy.

there I said it, I should be a regional trainer. I just trained you for free.
Click to expand...

Great training dumbass - goes to show how educated you are about managed care access. Sounds like you’re one of the diabetes reps drinking the kool aid that all of the obesity reps are stealing your business. For every 10 scripts you have an obesity rep gets 1 which is why providers use ozempic off label for weight.
 


anonymous said:
Everyone on Saxenda put on wegovy
Everyone on ozempic for weight loss put on wegovy.

there I said it, I should be a regional trainer. I just trained you for free.
Click to expand...
This will be my strategy at least until I find out that to be paid on Wegovy, you have to maintain a certain Saxenda volume. I am sure that the IC structure will be a dumpster fire as is the storied history for Novo.
 






Sema 2.4? Really Novo? You can’t (won’t) even tell your reps where Saxenda is covered? Why I’m sure things will be different now right? Better drug but an even more cumbersome selling environment? Way TO Go Novo!
 


Bigger headache?
Getting an office to write wegovy for the first time With the coupon card

or

keep them on therapy 6 months from now when card runs out and there is a tidal wave of pa coming back?
 










anonymous said:
truly a loss.... they cared.
Click to expand...
Truer words have never been spoken. This training group doesn't understand the market. Wegovy will be a piece of cake to sell, the numbers speak for themselves and doctors know how Saxenda works. Why could we not just leave well enough alone and use the Flex Touch pen and also create a much simpler copay program? Virtually all of our time will be spent figuring out the copay card intricacies, explaining the de-escalation card starting around the week of shutdown, chasing down pharmacy issues, and praying that whatever vendor that will be responsible for answering 833-4WEGOVY has not hired a bunch of knuckleheads that don't know what is going on!
Happy launch and get those printers ready to print some PI's!
 


EXACTLY


anonymous said:
Truer words have never been spoken. This training group doesn't understand the market. Wegovy will be a piece of cake to sell, the numbers speak for themselves and doctors know how Saxenda works. Why could we not just leave well enough alone and use the Flex Touch pen and also create a much simpler copay program? Virtually all of our time will be spent figuring out the copay card intricacies, explaining the de-escalation card starting around the week of shutdown, chasing down pharmacy issues, and praying that whatever vendor that will be responsible for answering 833-4WEGOVY has not hired a bunch of knuckleheads that don't know what is going on!
Happy launch and get those printers ready to print some PI's!
Click to expand...
 



Write your reply...
Top Bottom
Back
Quote